News & Events

• March 1, 2017
  

  Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action

  McNerney R, Clark TG, Campino S, Rodrigues C, Dolinger D, Smith L, Cabibbe AM, Dheda K, Schito M. Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2017 Mar;56:130–5.

• October 24, 2016
  

  Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches

  Hanna D, Romero K, Schito M. Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2016 Oct 24;56:208–11.

• October 1, 2016
  

  Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project

  Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project. The Lancet Infectious Diseases. 2016 Oct;16(10):1185–92.

• April 1, 2016
  

  Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers

  Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A. Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers. The Lancet Infectious Diseases. 2016 Apr;16(4):e34–46.

• April 1, 2016
  

  World TB Day 2016: Reflections on the Global TB Emergency

  Zumla A, Schito M, Chakaya J, Marais B, Mwaba P, Migliori GB, Hoelscher M, Maeurer M, Wallis RS. World TB Day 2016: Reflections on the Global TB Emergency. The Lancet Respiratory Medicine. 2016 Apr;4(4):249–51.